Therapy for Stage IV Non–Small Cell Lung Cancer With Driver Alterations: ASCO Living Guideline, Version 2024.2 https://t.co/TfCBm4vfOs https://t.co/f3VLgsMxMM
Therapy for Stage IV Non-Small Cell Lung Cancer With Driver Alterations: ASCO Living Guideline, Version 2024.2.
Mentions
Extended reach
Total likes
Video views
Mentions per month
Jun 2024 – Aug 2025Where it's discussed
-
X / Twitter111 posts
-
Bluesky3 posts
-
Reddit3 posts
-
YouTube2 videos
-
News2 articles
AI synopsis
What people are saying
Numerous posts reference the guideline's focus on personalized medicine and the significance of treating specific genetic alterations, highlighting areas of ongoing research. Phrases like 'area of great interest' and 'updated ASCO guidelines' suggest an active engagement with the content and an acknowledgment of its importance in clinical practice.
Many posts express support for the updated guidelines, indicating a consensus on the importance of the information.
The discussions reflect a high level of curiosity and attentiveness to advancements in lung cancer treatment.
While some posts are simple announcements, others delve into specifics about the therapies and implications for patient care.
The prevailing sentiment is that the updated guidelines will significantly influence treatment approaches for Stage IV Non-Small Cell Lung Cancer.
Abstract in brief
- The ASCO Living Guideline offers updated recommendations for treatment options in patients with Stage IV Non-Small Cell Lung Cancer (NSCLC) who have specific genetic driver alterations.
- It emphasizes the importance of personalized medicine, highlighting targeted therapies and immunotherapies that can improve outcomes based on individual genetic profiles.
- The guideline underscores the necessity of ongoing research and updates, ensuring clinicians utilize the most effective treatments as new evidence emerges.
Top posts
Most liked on X and BlueskyNew living guideline update of Therapy for Stage IV Non-Small Cell Lung Cancer With Driver Alterations - @ASCO https://t.co/VVCQ527kUv #ASCO #LungCancer #NSCLC #OncoDaily #Oncology https://t.co/FkmgBJEO1g
We’re accepting comments on our draft living guideline Therapy for Stage IV Non-Small Cell Lung Cancer With Driver Alterations. Submit feedback to us by September 3: https://t.co/MAGk5irxYR https://t.co/JmKHwxt3Vu
ASCO updated Guideline, Version 2024.2 is now live Published November 12, 2024 Therapy for Stage IV Non–Small Cell Lung Cancer With Driver Alterations. To me, treating uncommon EGFR mutations (G719X, L861Q, S7681) is still an area of great interest.
The OncoAlert Round Up、今、YouTubeチャンネルで日本語字幕付きで公開中
All mentions
Updated Guidelines for Stage IV Non-Small Cell Lung Cancer Treatment
This video discusses survival outcomes and treatment options for Stage IV Non-Small Cell Lung Cancer (NSCLC) with genetic driver alterations, emphasizing personalized medicine and the latest ASCO Living Guideline for…
Therapy for Stage IV NSCLC With Driver Alterations: ASCO Living Guideline Update 2024.2
RT @ASCO: We’re accepting comments on our draft living guideline Therapy for Stage IV Non-Small Cell Lung Cancer With Driver Alterations.…
We’re accepting comments on our draft living guideline Therapy for Stage IV Non-Small Cell Lung Cancer With Driver Alterations. Submit feedback to us by September 3: brnw.ch/21wV8b2
We’re accepting comments on our draft living guideline Therapy for Stage IV Non-Small Cell Lung Cancer With Driver Alterations. Submit feedback to us by September 3: https://t.co/MAGk5irxYR https://t.co/JmKHwxt3Vu
.@JCO_ASCO Therapy for Stage IV Non-Small Cell Lung Cancer With Driver Alterations: ASCO Living Guideline, Version 2025.1. PMID:40674661 https://t.co/HzZ4D4Zl5i
Therapy for Stage IV Non–Small Cell Lung Cancer With Driver Alterations: ASCO Living Guideline, Version 2025.1 | Journal of Clinical Oncology ascopubs.org/doi/10.1200/...
ASCO updated Guideline, Version 2024.2 is now live Published November 12, 2024 Therapy for Stage IV Non–Small Cell Lung Cancer With Driver Alterations. To me, treating uncommon EGFR mutations (G719X, L861Q, S7681) is still an area of great interest.
RT @OscarTahuahua: Therapy for Stage IV Non–Small Cell Lung Cancer With Driver Alterations: ASCO Living Guideline, Version 2024.2 @JCO_ASCO…
RT @OncoAlert: The OncoAlert Round Up、今、YouTubeチャンネルで日本語字幕付きで公開中
RT @OncoAlert: The OncoAlert Round Up、今、YouTubeチャンネルで日本語字幕付きで公開中
The OncoAlert Round Up、今、YouTubeチャンネルで日本語字幕付きで公開中
Therapy for Stage IV Non–Small Cell #LungCancer With Driver Alterations: ASCO Living Guideline, Version 2024.2 https://t.co/6mhECIwnTN #Cancer
Therapy for Stage IV Non–Small Cell Lung Cancer With Driver Alterations https://t.co/KFQYjxjN1W
RT @dr_yakupergun: Therapy for Stage IV Non–Small Cell Lung Cancer With Driver Alterations: ASCO Living Guideline, Version 2024.2 https://…
RT @dr_yakupergun: Therapy for Stage IV Non–Small Cell Lung Cancer With Driver Alterations: ASCO Living Guideline, Version 2024.2 https://…
RT @jillfeldman4:
RT @jillfeldman4:
RT @OscarTahuahua: Therapy for Stage IV Non–Small Cell Lung Cancer With Driver Alterations: ASCO Living Guideline, Version 2024.2 @JCO_ASCO…
RT @OscarTahuahua: Therapy for Stage IV Non–Small Cell Lung Cancer With Driver Alterations: ASCO Living Guideline, Version 2024.2 @JCO_ASCO…
RT @OscarTahuahua: Therapy for Stage IV Non–Small Cell Lung Cancer With Driver Alterations: ASCO Living Guideline, Version 2024.2 @JCO_ASCO…
RT @OscarTahuahua: Therapy for Stage IV Non–Small Cell Lung Cancer With Driver Alterations: ASCO Living Guideline, Version 2024.2 @JCO_ASCO…
RT @dr_yakupergun: Therapy for Stage IV Non–Small Cell Lung Cancer With Driver Alterations: ASCO Living Guideline, Version 2024.2 https://…
RT @jillfeldman4:
RT @dr_yakupergun: Therapy for Stage IV Non–Small Cell Lung Cancer With Driver Alterations: ASCO Living Guideline, Version 2024.2 https://…
RT @jillfeldman4:
RT @jillfeldman4:
RT @dr_yakupergun: Therapy for Stage IV Non–Small Cell Lung Cancer With Driver Alterations: ASCO Living Guideline, Version 2024.2 https://…
RT @jillfeldman4:
RT @jillfeldman4:
RT @jillfeldman4:
RT @jillfeldman4:
RT @dr_yakupergun: Therapy for Stage IV Non–Small Cell Lung Cancer With Driver Alterations: ASCO Living Guideline, Version 2024.2 https://…
RT @dr_yakupergun: Therapy for Stage IV Non–Small Cell Lung Cancer With Driver Alterations: ASCO Living Guideline, Version 2024.2 https://…
RT @jillfeldman4:
RT @jillfeldman4:
RT @dr_yakupergun: Therapy for Stage IV Non–Small Cell Lung Cancer With Driver Alterations: ASCO Living Guideline, Version 2024.2 https://…
RT @jillfeldman4:
RT @dr_yakupergun: Therapy for Stage IV Non–Small Cell Lung Cancer With Driver Alterations: ASCO Living Guideline, Version 2024.2 https://…
RT @jillfeldman4:
RT @jillfeldman4:
RT @jillfeldman4:
RT @jillfeldman4:
RT @jillfeldman4:
RT @dr_yakupergun: Therapy for Stage IV Non–Small Cell Lung Cancer With Driver Alterations: ASCO Living Guideline, Version 2024.2 https://…
RT @dr_yakupergun: Therapy for Stage IV Non–Small Cell Lung Cancer With Driver Alterations: ASCO Living Guideline, Version 2024.2 https://…
RT @dr_yakupergun: Therapy for Stage IV Non–Small Cell Lung Cancer With Driver Alterations: ASCO Living Guideline, Version 2024.2 https://…
RT @dr_yakupergun: Therapy for Stage IV Non–Small Cell Lung Cancer With Driver Alterations: ASCO Living Guideline, Version 2024.2 https://…
RT @jillfeldman4:
RT @jillfeldman4:
RT @jillfeldman4:
RT @jillfeldman4:
RT @jillfeldman4:
RT @jillfeldman4:
RT @jillfeldman4:
RT @jillfeldman4:
RT @dr_yakupergun: Therapy for Stage IV Non–Small Cell Lung Cancer With Driver Alterations: ASCO Living Guideline, Version 2024.2 https://…
RT @jillfeldman4:
RT @dr_yakupergun: Therapy for Stage IV Non–Small Cell Lung Cancer With Driver Alterations: ASCO Living Guideline, Version 2024.2 https://…
RT @jillfeldman4:
RT @jillfeldman4:
RT @dr_yakupergun: Therapy for Stage IV Non–Small Cell Lung Cancer With Driver Alterations: ASCO Living Guideline, Version 2024.2 https://…
RT @jillfeldman4:
RT @dr_yakupergun: Therapy for Stage IV Non–Small Cell Lung Cancer With Driver Alterations: ASCO Living Guideline, Version 2024.2 https://…
RT @jillfeldman4:
RT @jillfeldman4:
RT @jillfeldman4:
RT @jillfeldman4:
RT @jillfeldman4:
RT @dr_yakupergun: Therapy for Stage IV Non–Small Cell Lung Cancer With Driver Alterations: ASCO Living Guideline, Version 2024.2 https://…
RT @jillfeldman4:
RT @jillfeldman4:
RT @jillfeldman4:
【文献メモ】〈Guideline〉 Therapy for Stage IV Non–Small Cell Lung Cancer With Driver Alterations: ASCO Living Guideline, Version 2024.2 (J. Clin. Oncol. November 12, 2024.) https://t.co/obU3oSLMuu
RT @jillfeldman4:
RT @jillfeldman4:
RT @dr_yakupergun: Therapy for Stage IV Non–Small Cell Lung Cancer With Driver Alterations: ASCO Living Guideline, Version 2024.2 https://…
RT @jillfeldman4:
RT @dr_yakupergun: Therapy for Stage IV Non–Small Cell Lung Cancer With Driver Alterations: ASCO Living Guideline, Version 2024.2 https://…
RT @jillfeldman4:
RT @jillfeldman4:
RT @jillfeldman4:
RT @dr_yakupergun: Therapy for Stage IV Non–Small Cell Lung Cancer With Driver Alterations: ASCO Living Guideline, Version 2024.2 https://…
RT @dr_yakupergun: Therapy for Stage IV Non–Small Cell Lung Cancer With Driver Alterations: ASCO Living Guideline, Version 2024.2 https://…
RT @dr_yakupergun: Therapy for Stage IV Non–Small Cell Lung Cancer With Driver Alterations: ASCO Living Guideline, Version 2024.2 https://…
RT @dr_yakupergun: Therapy for Stage IV Non–Small Cell Lung Cancer With Driver Alterations: ASCO Living Guideline, Version 2024.2 https://…
RT @dr_yakupergun: Therapy for Stage IV Non–Small Cell Lung Cancer With Driver Alterations: ASCO Living Guideline, Version 2024.2 https://…
RT @dr_yakupergun: Therapy for Stage IV Non–Small Cell Lung Cancer With Driver Alterations: ASCO Living Guideline, Version 2024.2 https://…
RT @dr_yakupergun: Therapy for Stage IV Non–Small Cell Lung Cancer With Driver Alterations: ASCO Living Guideline, Version 2024.2 https://…
RT @dr_yakupergun: Therapy for Stage IV Non–Small Cell Lung Cancer With Driver Alterations: ASCO Living Guideline, Version 2024.2 https://…
RT @dr_yakupergun: Therapy for Stage IV Non–Small Cell Lung Cancer With Driver Alterations: ASCO Living Guideline, Version 2024.2 https://…
RT @dr_yakupergun: Therapy for Stage IV Non–Small Cell Lung Cancer With Driver Alterations: ASCO Living Guideline, Version 2024.2 https://…
Therapy for Stage IV Non–Small Cell Lung Cancer With Driver Alterations: ASCO Living Guideline, Version 2024.2 | Journal of Clinical Oncology https://t.co/sZCXZR9lW9
RT @dr_yakupergun: Therapy for Stage IV Non–Small Cell Lung Cancer With Driver Alterations: ASCO Living Guideline, Version 2024.2 https://…
RT @dr_yakupergun: Therapy for Stage IV Non–Small Cell Lung Cancer With Driver Alterations: ASCO Living Guideline, Version 2024.2 https://…
RT @dr_yakupergun: Therapy for Stage IV Non–Small Cell Lung Cancer With Driver Alterations: ASCO Living Guideline, Version 2024.2 https://…
RT @dr_yakupergun: Therapy for Stage IV Non–Small Cell Lung Cancer With Driver Alterations: ASCO Living Guideline, Version 2024.2 https://…
RT @dr_yakupergun: Therapy for Stage IV Non–Small Cell Lung Cancer With Driver Alterations: ASCO Living Guideline, Version 2024.2 https://…
RT @dr_yakupergun: Therapy for Stage IV Non–Small Cell Lung Cancer With Driver Alterations: ASCO Living Guideline, Version 2024.2 https://…
RT @dr_yakupergun: Therapy for Stage IV Non–Small Cell Lung Cancer With Driver Alterations: ASCO Living Guideline, Version 2024.2 https://…
RT @dr_yakupergun: Therapy for Stage IV Non–Small Cell Lung Cancer With Driver Alterations: ASCO Living Guideline, Version 2024.2 https://…
RT @dr_yakupergun: Therapy for Stage IV Non–Small Cell Lung Cancer With Driver Alterations: ASCO Living Guideline, Version 2024.2 https://…
RT @dr_yakupergun: Therapy for Stage IV Non–Small Cell Lung Cancer With Driver Alterations: ASCO Living Guideline, Version 2024.2 https://…
RT @dr_yakupergun: Therapy for Stage IV Non–Small Cell Lung Cancer With Driver Alterations: ASCO Living Guideline, Version 2024.2 https://…
RT @dr_yakupergun: Therapy for Stage IV Non–Small Cell Lung Cancer With Driver Alterations: ASCO Living Guideline, Version 2024.2 https://…
RT @dr_yakupergun: Therapy for Stage IV Non–Small Cell Lung Cancer With Driver Alterations: ASCO Living Guideline, Version 2024.2 https://…
RT @dr_yakupergun: Therapy for Stage IV Non–Small Cell Lung Cancer With Driver Alterations: ASCO Living Guideline, Version 2024.2 https://…
RT @dr_yakupergun: Therapy for Stage IV Non–Small Cell Lung Cancer With Driver Alterations: ASCO Living Guideline, Version 2024.2 https://…
RT @dr_yakupergun: Therapy for Stage IV Non–Small Cell Lung Cancer With Driver Alterations: ASCO Living Guideline, Version 2024.2 https://…
RT @dr_yakupergun: Therapy for Stage IV Non–Small Cell Lung Cancer With Driver Alterations: ASCO Living Guideline, Version 2024.2 https://…
RT @dr_yakupergun: Therapy for Stage IV Non–Small Cell Lung Cancer With Driver Alterations: ASCO Living Guideline, Version 2024.2 https://…
RT @dr_yakupergun: Therapy for Stage IV Non–Small Cell Lung Cancer With Driver Alterations: ASCO Living Guideline, Version 2024.2 https://…
Therapy for Stage IV Non–Small Cell Lung Cancer With Driver Alterations: ASCO Living Guideline, Version 2024.2 https://t.co/TfCBm4vfOs https://t.co/f3VLgsMxMM
Updated ASCO guidelines Therapy for Stage IV Non–Small Cell Lung Cancer With Driver Alterations: ASCO Living Guideline, Version 2024.2 | Journal of Clinical Oncology https://t.co/Ucq0CbRVM5
New living guideline update of Therapy for Stage IV Non-Small Cell Lung Cancer With Driver Alterations - @ASCO https://t.co/VVCQ527kUv #ASCO #LungCancer #NSCLC #OncoDaily #Oncology https://t.co/FkmgBJEO1g